Gainers
- Quince Therapeutics QNCX shares increased by 66.3% to $1.4 during Tuesday's pre-market session. The market value of their outstanding shares is at $50.7 million.
- Novo Integrated Sciences NVOS stock increased by 37.86% to $0.14. The company's market cap stands at $19.3 million.
- Qualigen Therapeutics QLGN stock increased by 28.57% to $1.26. The market value of their outstanding shares is at $5.3 million.
- Pear Therapeutics PEAR shares rose 27.71% to $0.27. The company's market cap stands at $37.4 million.
- Coya Therapeutics COYA stock rose 23.51% to $4.99. The market value of their outstanding shares is at $49.4 million.
- Frequency Therapeutics FREQ shares rose 13.39% to $0.56. The company's market cap stands at $19.6 million.
Losers
- Altimmune ALT shares declined by 35.9% to $7.0 during Tuesday's pre-market session. The company's market cap stands at $344.9 million.
- Bluejay Diagnostics BJDX stock declined by 30.35% to $0.38. The market value of their outstanding shares is at $7.5 million. The company's, Q4 earnings came out yesterday.
- Connect Biopharma Hldgs CNTB shares fell 16.67% to $1.1. The market value of their outstanding shares is at $60.5 million.
- Monopar Therapeutics MNPR shares decreased by 16.36% to $2.25. The market value of their outstanding shares is at $29.0 million.
- Gelesis Holdings GLS stock fell 14.73% to $0.18. The company's market cap stands at $13.1 million.
- Allarity Therapeutics ALLR shares declined by 10.57% to $0.13. The company's market cap stands at $3.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in